Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 5.01
(4.16%)
CNY 5.01
(4.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.27 Billion CNY | -12.35% |
| 2022 | 1.45 Billion CNY | 17.98% |
| 2021 | 1.23 Billion CNY | 15.15% |
| 2020 | 1.07 Billion CNY | 23.35% |
| 2019 | 869.6 Million CNY | 2.81% |
| 2018 | 845.81 Million CNY | 2.78% |
| 2017 | 822.96 Million CNY | 59.32% |
| 2016 | 516.55 Million CNY | 9.12% |
| 2015 | 473.36 Million CNY | 8.32% |
| 2014 | 437 Million CNY | 17.05% |
| 2013 | 373.34 Million CNY | -1.7% |
| 2012 | 379.79 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.32 Billion CNY | 5.31% |
| 2024 Q1 | 1.25 Billion CNY | -1.36% |
| 2024 Q3 | 1.24 Billion CNY | -5.86% |
| 2023 FY | 1.27 Billion CNY | -12.35% |
| 2023 Q1 | 1.49 Billion CNY | 2.26% |
| 2023 Q3 | 1.47 Billion CNY | 4.7% |
| 2023 Q4 | 1.27 Billion CNY | -13.39% |
| 2023 Q2 | 1.4 Billion CNY | -5.47% |
| 2022 Q3 | 1.48 Billion CNY | 7.77% |
| 2022 Q2 | 1.37 Billion CNY | 3.61% |
| 2022 Q1 | 1.32 Billion CNY | 7.63% |
| 2022 FY | 1.45 Billion CNY | 17.98% |
| 2022 Q4 | 1.45 Billion CNY | -1.84% |
| 2021 Q3 | 1.26 Billion CNY | 3.63% |
| 2021 Q1 | 1.12 Billion CNY | 5.12% |
| 2021 Q2 | 1.21 Billion CNY | 7.92% |
| 2021 FY | 1.23 Billion CNY | 15.15% |
| 2021 Q4 | 1.23 Billion CNY | -2.04% |
| 2020 Q2 | 1.08 Billion CNY | 21.09% |
| 2020 Q3 | 1.09 Billion CNY | 0.49% |
| 2020 Q4 | 1.07 Billion CNY | -1.84% |
| 2020 FY | 1.07 Billion CNY | 23.35% |
| 2020 Q1 | 898.06 Million CNY | 3.27% |
| 2019 Q4 | 869.6 Million CNY | 8.38% |
| 2019 Q2 | 831.1 Million CNY | -2.45% |
| 2019 Q1 | 851.96 Million CNY | 0.73% |
| 2019 FY | 869.6 Million CNY | 2.81% |
| 2019 Q3 | 802.37 Million CNY | -3.46% |
| 2018 Q3 | 842.84 Million CNY | -0.07% |
| 2018 FY | 845.81 Million CNY | 2.78% |
| 2018 Q4 | 845.81 Million CNY | 0.35% |
| 2018 Q2 | 843.41 Million CNY | 5.39% |
| 2018 Q1 | 800.29 Million CNY | -2.76% |
| 2017 FY | 822.96 Million CNY | 59.32% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 553.07 Million CNY | 0.0% |
| 2017 Q3 | 799.17 Million CNY | 44.5% |
| 2017 Q4 | 822.96 Million CNY | 2.98% |
| 2016 Q4 | 516.55 Million CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 516.55 Million CNY | 9.12% |
| 2015 Q4 | 473.36 Million CNY | 0.0% |
| 2015 Q2 | 414.73 Million CNY | 0.0% |
| 2015 FY | 473.36 Million CNY | 8.32% |
| 2014 FY | 437 Million CNY | 17.05% |
| 2013 FY | 373.34 Million CNY | -1.7% |
| 2012 FY | 379.79 Million CNY | 0.0% |